Pneumococcal disease in sub-Saharan African children: what is the effectiveness of the pneumococcal conjugate vaccine?
Afr. j. respir. Med
; 4(1): 8-15, 2008. ilus
Artigo
em Inglês
| AIM
| ID: biblio-1257891
Biblioteca responsável:
CG1.1
ABSTRACT
Streptococcus pneumoniae is still a leading cause of morbidity and mortality among children in developing countries. Young children represent a high-risk group for severe pneumococcal disease; not only because of their physio-logical susceptibility but also because polysaccharide vaccines are not effective for them. Pneumococcal conjugate vaccines have shown a high protection against pneumococcal diseases all over the world. Therefore; the expanded use of this vaccine must be considered as a major world health priority
Buscar no Google
Índice:
AIM (África)
Assunto principal:
Infecções Pneumocócicas
/
Streptococcus pneumoniae
/
Vacinas
/
Criança
/
Fatores de Risco
/
Revisão
Tipo de estudo:
Estudo de etiologia
/
Fatores de risco
Idioma:
Inglês
Revista:
Afr. j. respir. Med
Ano de publicação:
2008
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS